By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Dynamic Business Location.

Etihad Airways uses coronarvirus risk tool from the Viennese startup Medicus AI

Covid-19 self-assessment © Etihad Airways: New COVID-19 tool developed by the Viennese startup Medicus AI

The assessment tool should take five minutes. This self-testing tool is designed to enable a relatively accurate assessment of the risk of a potential infection with COVID-19 by the passengers. The technology for this test is provided by the Viennese medtech startup Medicus AI.

Medicus AI launched the world's first coronavirus App certified as a medical product in cooperation with the Luxembourg-based company BioneXt Lab. The tool is now being used in partnership with Etihad and has been integrated into this App. It functions on the basis of criteria specified by the World Health Organisation WHO and is updated daily. It is available in English for the time being and will be successively expanded to enable testing in Arabic, French, German and Portuguese.
Frank Meyer, Chief Digital Officer, Etihad Airways, said: "We know that health and wellbeing will be a major factor impacting the travel decisions of our guests and are committed to ensuring their continued safety and peace of mind." The partnership with Medicus AI is one of the possibilities to adapt operations to the new demands placed on the travel industry as a result of COVID-19.

Read more here about COVID-19 research projects in Austria.

Read more:

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin



Meet us at events, seminars and trade shows - worldwide.

  • China International Fair for Investment & Trade

    08.09. - 11.09. 2020, Xiamen, China

  • Finanzgipfel 2020

    17.09.2020/ 08:00 , Frankfurt, Deutschland

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

More testimonials

news from the business location Austria

Novartis extends penicillin production in Tyrol

The Swiss pharmaceutical company Novartis decides on location Austria and invests 2.5 Billion EURO into penicillin production.

“Cash or card?” - Austria, the coronavirus pandemic and the increasing trend towards cashless payment.

The number of cashless transactions in Austria has been increasing for years. This upward trend once again experienced a tremendous boost due to the coronavirus pandemic.

More news All blog posts